Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Value in health 2014-11, Vol.17 (7), p.A396-A396
Hauptverfasser: Silverio, N, Sequeira, L, Meletiche, D
Format: Artikel
Sprache:eng
Schlagworte:
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2014.08.887